Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members
Objective Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real‐world epidemiology of endometriosis in an unselected low‐risk population in Israel. Design Retrospective population‐bas...
Uloženo v:
| Vydáno v: | BJOG : an international journal of obstetrics and gynaecology Ročník 125; číslo 1; s. 55 - 62 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Wiley Subscription Services, Inc
01.01.2018
|
| Témata: | |
| ISSN: | 1470-0328, 1471-0528, 1471-0528 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Objective
Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real‐world epidemiology of endometriosis in an unselected low‐risk population in Israel.
Design
Retrospective population‐based study.
Setting and sample
The computerised databases of Maccabi Healthcare Services (MHS), a 2‐million‐member healthcare provider representing a quarter of the Israeli population.
Methods
The crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000–2015) rates of diagnosed endometriosis (ICD‐9‐CM 617.xx) were assessed among women aged 15–55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries.
Main outcome measures
Prevalence and incidence of diagnosed endometriosis in MHS.
Results
The point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5–11.0). Women aged 40–44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7–19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly‐diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5–8.0).
Conclusions
We observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high‐risk populations, in line with population‐based estimates from European databases (range 0.8–1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice.
Tweetable
Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting.
Tweetable
Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting. |
|---|---|
| AbstractList | Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting. Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real-world epidemiology of endometriosis in an unselected low-risk population in Israel.OBJECTIVEEndometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real-world epidemiology of endometriosis in an unselected low-risk population in Israel.Retrospective population-based study.DESIGNRetrospective population-based study.The computerised databases of Maccabi Healthcare Services (MHS), a 2-million-member healthcare provider representing a quarter of the Israeli population.SETTING AND SAMPLEThe computerised databases of Maccabi Healthcare Services (MHS), a 2-million-member healthcare provider representing a quarter of the Israeli population.The crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000-2015) rates of diagnosed endometriosis (ICD-9-CM 617.xx) were assessed among women aged 15-55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries.METHODSThe crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000-2015) rates of diagnosed endometriosis (ICD-9-CM 617.xx) were assessed among women aged 15-55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries.Prevalence and incidence of diagnosed endometriosis in MHS.MAIN OUTCOME MEASURESPrevalence and incidence of diagnosed endometriosis in MHS.The point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5-11.0). Women aged 40-44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7-19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly-diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5-8.0).RESULTSThe point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5-11.0). Women aged 40-44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7-19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly-diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5-8.0).We observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high-risk populations, in line with population-based estimates from European databases (range 0.8-1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice.CONCLUSIONSWe observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high-risk populations, in line with population-based estimates from European databases (range 0.8-1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice.Endometriosis diagnosed in 1% of women, according to a large population-based study in a community setting.TWEETABLE ABSTRACTEndometriosis diagnosed in 1% of women, according to a large population-based study in a community setting. Objective Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real‐world epidemiology of endometriosis in an unselected low‐risk population in Israel. Design Retrospective population‐based study. Setting and sample The computerised databases of Maccabi Healthcare Services (MHS), a 2‐million‐member healthcare provider representing a quarter of the Israeli population. Methods The crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000–2015) rates of diagnosed endometriosis (ICD‐9‐CM 617.xx) were assessed among women aged 15–55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries. Main outcome measures Prevalence and incidence of diagnosed endometriosis in MHS. Results The point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5–11.0). Women aged 40–44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7–19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly‐diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5–8.0). Conclusions We observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high‐risk populations, in line with population‐based estimates from European databases (range 0.8–1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice. Tweetable Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting. Tweetable Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting. Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real-world epidemiology of endometriosis in an unselected low-risk population in Israel. Retrospective population-based study. The computerised databases of Maccabi Healthcare Services (MHS), a 2-million-member healthcare provider representing a quarter of the Israeli population. The crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000-2015) rates of diagnosed endometriosis (ICD-9-CM 617.xx) were assessed among women aged 15-55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries. Prevalence and incidence of diagnosed endometriosis in MHS. The point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5-11.0). Women aged 40-44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7-19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly-diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5-8.0). We observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high-risk populations, in line with population-based estimates from European databases (range 0.8-1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice. Endometriosis diagnosed in 1% of women, according to a large population-based study in a community setting. ObjectiveEndometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to describe the real-world epidemiology of endometriosis in an unselected low-risk population in Israel.DesignRetrospective population-based study.Setting and sampleThe computerised databases of Maccabi Healthcare Services (MHS), a 2-million-member healthcare provider representing a quarter of the Israeli population.MethodsThe crude point prevalence (31 December 2015; diagnosed since 1998) and annual incidence (2000-2015) rates of diagnosed endometriosis (ICD-9-CM 617.xx) were assessed among women aged 15-55 years. Prevalent patients were characterised in terms of sociodemographic and clinical characteristics, including validated MHS infertility and chronic disease registries.Main outcome measuresPrevalence and incidence of diagnosed endometriosis in MHS.ResultsThe point prevalence of endometriosis [n = 6146, mean age 40.4 ± 8.0 years (SD)] was 10.8 per 1000 (95% CI 10.5-11.0). Women aged 40-44 years had the highest prevalence rate of 18.6 per 1000 (95% CI 17.7-19.5). Infertility was documented in 37% of patients. A total of 6045 patients were included in the cohort of newly-diagnosed endometriosis (mean age 34.0 ± 8.1 years), corresponding to an average annual incidence rate of 7.2 per 10 000 (95% CI 6.5-8.0).ConclusionsWe observed a substantially lower prevalence of diagnosed endometriosis compared with previous reports in high-risk populations, in line with population-based estimates from European databases (range 0.8-1.8%). Further characterisation of this cohort may help to understand what affects the prevalence of endometriosis in Israel, and to promote earlier diagnosis and improve management in clinical practice.Tweetable abstractEndometriosis diagnosed in 1% of women, according to a large population-based study in a community setting.Tweetable abstractEndometriosis diagnosed in 1% of women, according to a large population-based study in a community setting. |
| Author | Eisenberg, VH Chodick, G Shalev, V Weil, C |
| Author_xml | – sequence: 1 givenname: VH surname: Eisenberg fullname: Eisenberg, VH email: aizenber_v@mac.org.il organization: Tel Aviv University – sequence: 2 givenname: C surname: Weil fullname: Weil, C organization: Maccabi Institute for Research and Innovation, Maccabi Healthcare Services – sequence: 3 givenname: G surname: Chodick fullname: Chodick, G organization: Tel Aviv University – sequence: 4 givenname: V surname: Shalev fullname: Shalev, V organization: Tel Aviv University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28444957$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkctu3CAUhlGVqrm06-4qpG66ccLFYLu7NkpvipRNu0bYHDJEYKZgJ5qu-gh5xjxJ8cyki0hV2fAD3_9z4ByjgzGOgNBrSk5pGWe0bmhFBGtPF0WfoaO_OwdbTSrCWXuIjnO-IYRKRvgLdMjauq470RyhXxdrZyC46OP1BkeLYTQxwJRczC6_xxp7na4Br-N69npycXz4fd_rDAYbPelF4TzNZoNtiqHgK9B-Wg06FU-KtyU84Ts3rTDDwXlfAnCA0EPKL9Fzq32GV_v5BP34dPH9_Et1efX56_mHy2rg5UmVkRK4llJIUbcWoG46Ztty1jVEw7IW0kojhOig16QbqNCSdcKStreaGH6C3u1ySz0_Z8iTCi4P4L0eIc5Z0bZjnNcNJwV9-wS9iXMaS3WKdk1DOeOUFurNnpr7AEatkws6bdTjrxZA7IAhxZwTWDW4aft5U9LOK0rU0j219EotvdqqJfjsie8x-t-O_U13zsPmf7j6-O1q5_sDraOrRA |
| CitedBy_id | crossref_primary_10_1016_j_ejogrb_2020_08_012 crossref_primary_10_1515_sjpain_2019_0004 crossref_primary_10_1016_j_ijnsa_2025_100425 crossref_primary_10_1111_1471_0528_18086 crossref_primary_10_1038_s41598_023_43999_7 crossref_primary_10_3390_biomedicines9101286 crossref_primary_10_1002_ijgo_15756 crossref_primary_10_1186_s12955_020_01579_7 crossref_primary_10_1177_13591053221085051 crossref_primary_10_1002_nop2_574 crossref_primary_10_1093_fampra_cmz041 crossref_primary_10_1055_s_0040_1713807 crossref_primary_10_1186_s13148_025_01828_w crossref_primary_10_3390_biomedicines9111536 crossref_primary_10_1016_j_ajog_2024_02_011 crossref_primary_10_1016_j_rbmo_2023_103649 crossref_primary_10_61622_rbgo_2025rbgo40 crossref_primary_10_18502_ijrm_v22i6_16798 crossref_primary_10_1186_s12905_023_02343_x crossref_primary_10_3390_healthcare9010029 crossref_primary_10_1097_MD_0000000000043163 crossref_primary_10_1186_s12893_020_01027_9 crossref_primary_10_1016_j_yexmp_2021_104616 crossref_primary_10_1016_j_beem_2018_10_001 crossref_primary_10_3389_fbiom_2023_1279358 crossref_primary_10_1097_j_pain_0000000000002036 crossref_primary_10_1007_s00216_025_05930_z crossref_primary_10_1016_j_envres_2020_110342 crossref_primary_10_1080_01443615_2019_1603209 crossref_primary_10_1080_03630242_2020_1781741 crossref_primary_10_1007_s00404_024_07878_4 crossref_primary_10_1177_17455057241227361 crossref_primary_10_1093_humupd_dmaf022 crossref_primary_10_1016_j_aace_2022_01_003 crossref_primary_10_1111_jnc_15795 crossref_primary_10_1007_s43032_020_00410_4 crossref_primary_10_1007_s43032_019_00094_5 crossref_primary_10_17116_repro2019250218 crossref_primary_10_1530_REP_18_0618 crossref_primary_10_1016_j_fertnstert_2021_07_1205 crossref_primary_10_1007_s10304_023_00503_8 crossref_primary_10_1038_s41539_025_00338_x crossref_primary_10_1111_aogs_14419 crossref_primary_10_1186_s12884_021_04342_y crossref_primary_10_1007_s12325_020_01331_z crossref_primary_10_3390_healthcare11101448 crossref_primary_10_1016_j_jri_2021_103307 crossref_primary_10_1186_s40001_023_01280_7 crossref_primary_10_1016_j_jfma_2019_06_015 crossref_primary_10_1186_s13048_022_01042_9 crossref_primary_10_3390_jcm11041133 crossref_primary_10_1134_S1022795418110133 crossref_primary_10_1177_22840265211035993 crossref_primary_10_3389_fendo_2021_739228 crossref_primary_10_1039_C9RA03525G crossref_primary_10_1186_s12905_019_0762_x crossref_primary_10_1111_jog_15945 crossref_primary_10_3390_ijerph17041194 crossref_primary_10_3390_ijms231911515 crossref_primary_10_18502_ijrm_v21i4_13272 crossref_primary_10_3389_fmed_2022_914356 crossref_primary_10_1080_14737167_2021_1936502 crossref_primary_10_1093_pm_pnaa463 crossref_primary_10_1016_j_clinbiochem_2020_04_005 crossref_primary_10_1186_s12876_023_02861_w crossref_primary_10_1111_aji_13486 crossref_primary_10_1016_j_critrevonc_2018_12_009 crossref_primary_10_1136_bmjopen_2019_030346 crossref_primary_10_1007_s43032_022_00966_3 crossref_primary_10_1111_aogs_14556 crossref_primary_10_1002_ijgo_15840 crossref_primary_10_3390_ijerph17113831 crossref_primary_10_1093_humupd_dmad025 crossref_primary_10_31083_j_ceog4910225 crossref_primary_10_3390_jcm14134761 crossref_primary_10_1016_j_ejogrb_2025_114083 crossref_primary_10_3390_ijms25084420 crossref_primary_10_1111_jog_15849 crossref_primary_10_1080_10408444_2018_1541073 crossref_primary_10_7717_peerj_19298 crossref_primary_10_1007_s43032_021_00705_0 crossref_primary_10_1016_j_saa_2022_121119 crossref_primary_10_1111_1471_0528_16447 crossref_primary_10_1080_13625187_2017_1374362 crossref_primary_10_1177_87564793211058696 crossref_primary_10_1136_bmjopen_2020_037095 crossref_primary_10_1080_09513590_2024_2425318 crossref_primary_10_1007_s10815_022_02662_2 crossref_primary_10_1007_s00404_022_06439_x crossref_primary_10_1038_s41598_024_70228_6 crossref_primary_10_1016_j_jmig_2019_11_018 crossref_primary_10_2188_jea_JE20200002 crossref_primary_10_1080_09513590_2021_1929151 crossref_primary_10_61622_rbgo_2024CR12 crossref_primary_10_1177_2284026520933141 crossref_primary_10_1186_s12884_019_2514_1 crossref_primary_10_3390_jcm10132971 crossref_primary_10_1093_humrep_deac186 crossref_primary_10_1016_S2213_8587_20_30402_2 crossref_primary_10_3390_bs14030199 crossref_primary_10_7759_cureus_28864 crossref_primary_10_1055_s_0043_1777748 crossref_primary_10_1186_s10397_021_01096_5 crossref_primary_10_3390_jcm11226727 crossref_primary_10_1038_s41598_021_99681_3 crossref_primary_10_1159_000543213 crossref_primary_10_1177_1066896918797438 crossref_primary_10_31744_einstein_journal_2025AO1259 crossref_primary_10_1007_s43032_020_00453_7 crossref_primary_10_1093_jamia_ocab279 crossref_primary_10_3389_fmed_2021_684474 crossref_primary_10_1016_j_ejogrb_2021_04_008 crossref_primary_10_1016_j_ygyno_2022_06_021 crossref_primary_10_1007_s00053_024_00841_6 crossref_primary_10_3892_etm_2018_6307 crossref_primary_10_1016_j_ajog_2020_01_041 crossref_primary_10_3390_jcm9051309 crossref_primary_10_1186_s12967_020_02471_0 crossref_primary_10_1007_s43032_023_01204_0 crossref_primary_10_1007_s00404_020_05472_y crossref_primary_10_1016_j_orcp_2022_04_002 crossref_primary_10_18502_ijrm_v20i8_11758 crossref_primary_10_1177_1934578X221114734 crossref_primary_10_1259_bjr_20180439 crossref_primary_10_1016_j_ajogmf_2021_100417 crossref_primary_10_1016_j_fertnstert_2024_07_037 crossref_primary_10_1016_j_rbmo_2018_11_021 crossref_primary_10_1016_j_ajog_2020_08_056 crossref_primary_10_1038_s41598_019_57207_y crossref_primary_10_1186_s12905_024_03188_8 crossref_primary_10_4103_GMIT_GMIT_81_19 crossref_primary_10_1186_s12978_018_0506_7 crossref_primary_10_1111_nyas_14468 crossref_primary_10_1186_s12978_024_01747_8 crossref_primary_10_1111_aji_13213 crossref_primary_10_1007_s00204_020_02834_y crossref_primary_10_1055_s_0042_1749430 crossref_primary_10_3389_fsurg_2022_963686 crossref_primary_10_1111_aogs_14364 crossref_primary_10_1097_JCMA_0000000000001154 crossref_primary_10_1007_s00418_017_1616_y crossref_primary_10_3390_ijerph18157861 crossref_primary_10_1016_j_anndiagpath_2019_151458 crossref_primary_10_1038_s41598_019_39700_6 crossref_primary_10_1186_s13287_019_1388_5 crossref_primary_10_4103_mgmj_mgmj_113_25 crossref_primary_10_18502_ijrm_v23i2_18494 crossref_primary_10_1007_s00404_020_05871_1 crossref_primary_10_3390_healthcare12242567 crossref_primary_10_1016_j_mce_2023_111883 crossref_primary_10_17749_2949_5873_rehabil_2024_26 crossref_primary_10_3390_ijerph18168754 crossref_primary_10_1055_a_2324_3778 crossref_primary_10_1055_a_1300_1887 crossref_primary_10_1016_j_biopha_2023_115554 crossref_primary_10_1097_MD_0000000000025080 crossref_primary_10_1038_s41591_018_0149_9 crossref_primary_10_4103_ijmr_IJMR_817_18 crossref_primary_10_3389_fped_2021_711979 crossref_primary_10_3889_oamjms_2022_9722 crossref_primary_10_3390_biomedicines10020390 crossref_primary_10_1016_j_fertnstert_2022_01_030 crossref_primary_10_1016_j_cca_2022_11_013 crossref_primary_10_1016_j_rbmo_2022_10_010 crossref_primary_10_1155_2018_1465348 crossref_primary_10_31393_morphology_journal_2025_31_1__08 crossref_primary_10_1016_j_rbmo_2023_103695 crossref_primary_10_1016_j_autrev_2021_102795 crossref_primary_10_1016_j_envres_2021_112584 crossref_primary_10_1016_j_ejogrb_2025_114595 crossref_primary_10_14309_crj_0000000000000872 crossref_primary_10_14202_vetworld_2023_2329_2339 crossref_primary_10_3390_jcm9020507 crossref_primary_10_3390_jcm9093035 crossref_primary_10_3390_cancers15235635 crossref_primary_10_3390_jcm13247530 crossref_primary_10_2196_23197 crossref_primary_10_3389_fimmu_2022_845944 crossref_primary_10_3389_fimmu_2023_1128301 crossref_primary_10_1007_s15013_020_4002_0 crossref_primary_10_1055_s_0040_1708885 crossref_primary_10_1177_17455057221130566 crossref_primary_10_1007_s00404_023_07125_2 crossref_primary_10_1111_aji_13095 crossref_primary_10_1186_s12905_022_02044_x crossref_primary_10_1146_annurev_biodatasci_092820_114757 crossref_primary_10_1186_s12978_024_01895_x crossref_primary_10_1155_2021_6663602 crossref_primary_10_3389_fpsyg_2024_1382067 crossref_primary_10_3390_jcm11040995 crossref_primary_10_1186_s13104_020_05070_w crossref_primary_10_3390_jcm10081616 crossref_primary_10_1093_biolre_ioaf089 crossref_primary_10_1016_j_cellsig_2021_110139 crossref_primary_10_1089_jwh_2021_0060 crossref_primary_10_1080_03007995_2020_1744120 crossref_primary_10_3390_jcm9061915 crossref_primary_10_1089_gtmb_2020_0152 crossref_primary_10_3390_biomedicines11113015 crossref_primary_10_1016_j_xfre_2024_03_002 crossref_primary_10_3390_ijerph18189919 crossref_primary_10_1016_j_ajog_2021_06_067 |
| Cites_doi | 10.1093/oxfordjournals.aje.a114634 10.1016/j.fertnstert.2007.07.1345 10.1016/j.ejogrb.2016.04.021 10.1023/B:EJEP.0000006635.36802.c8 10.1016/j.fertnstert.2011.05.090 10.1186/s12939-014-0115-1 10.1093/humrep/17.10.2715 10.1016/j.healthpol.2010.04.004 10.1016/0895-4356(92)90133-8 10.1300/J013v37n01_04 10.1016/j.ijcard.2010.08.002 10.1016/S0889-8545(05)70302-8 10.1177/1933719108330568 10.1016/j.bpobgyn.2004.01.007 10.1111/j.1749-6632.2002.tb02761.x 10.1371/journal.pone.0154227 10.1136/bmj.c2661 10.1111/j.1471-0528.2008.01878.x 10.1111/j.1471-0528.2008.01879.x 10.1016/j.ejogrb.2011.09.041 10.1300/J013v34n03_04 10.1016/j.fertnstert.2004.01.037 10.1186/1472-6963-11-288 10.1016/j.whi.2007.12.009 10.1093/aje/kwq143 10.1093/humrep/des316 10.1161/HYPERTENSIONAHA.114.03718 10.1016/j.fertnstert.2012.12.029 10.1001/jama.2014.6634 |
| ContentType | Journal Article |
| Copyright | 2017 Royal College of Obstetricians and Gynaecologists 2017 Royal College of Obstetricians and Gynaecologists. Copyright © 2018 Royal College of Obstetricians and Gynaecologists |
| Copyright_xml | – notice: 2017 Royal College of Obstetricians and Gynaecologists – notice: 2017 Royal College of Obstetricians and Gynaecologists. – notice: Copyright © 2018 Royal College of Obstetricians and Gynaecologists |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP ASE FPQ K6X K9. 7X8 |
| DOI | 10.1111/1471-0528.14711 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts British Nursing Index British Nursing Index (BNI) (1985 to Present) British Nursing Index ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) British Nursing Index Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-0528 |
| EndPage | 62 |
| ExternalDocumentID | 28444957 10_1111_1471_0528_14711 BJO14711 |
| Genre | article Journal Article |
| GeographicLocations | Israel |
| GeographicLocations_xml | – name: Israel |
| GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1B1 1OB 1OC 1~5 23N 24P 33P 36B 3O- 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 6J9 6P2 6PF 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AAHQN AAIPD AALRI AAMNL AANHP AANLZ AAONW AAQFI AASGY AAWTL AAXRX AAXUO AAYCA AAZKR ABCQN ABCUV ABEML ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACIUM ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBS EJD EMOBN EX3 F00 F01 F04 F5P FDB FEDTE FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NEJ NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RPZ RWI RX1 SAMSI SEW SSZ SUPJJ TEORI V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 XIF XV2 ZXP ZY1 ~IA ~WT 9DU AAYXX AEYWJ AGHNM AGQPQ AGYGG AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7QP ASE FPQ K6X K9. 7X8 |
| ID | FETCH-LOGICAL-c3711-d66e3a6656548fee4792f8c37970aeee4756f6d5559eba09c15a6295f08bfa0d3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 234 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000418194800011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1470-0328 1471-0528 |
| IngestDate | Thu Jul 10 22:12:55 EDT 2025 Fri Oct 03 04:10:21 EDT 2025 Wed Feb 19 02:37:13 EST 2025 Tue Nov 18 22:38:14 EST 2025 Sat Nov 29 02:27:22 EST 2025 Wed Jan 22 16:35:05 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | endometriosis epidemiology prevalence Diagnosis |
| Language | English |
| License | 2017 Royal College of Obstetricians and Gynaecologists. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3711-d66e3a6656548fee4792f8c37970aeee4756f6d5559eba09c15a6295f08bfa0d3 |
| Notes | This article is commented on by LR Goodman and JM Franasiak, p. 63 in this issue. To view this mini commentary visit https://doi.org/10.1111/1471-0528.14701 Linked article . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 28444957 |
| PQID | 1977132311 |
| PQPubID | 26244 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1892334730 proquest_journals_1977132311 pubmed_primary_28444957 crossref_citationtrail_10_1111_1471_0528_14711 crossref_primary_10_1111_1471_0528_14711 wiley_primary_10_1111_1471_0528_14711_BJO14711 |
| PublicationCentury | 2000 |
| PublicationDate | January 2018 2018-01-00 20180101 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationSubtitle | An International Journal of Obstetrics and Gynaecology |
| PublicationTitle | BJOG : an international journal of obstetrics and gynaecology |
| PublicationTitleAlternate | BJOG |
| PublicationYear | 2018 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2002; 17 2010; 97 2004; 82 2016; 209 1987; 125 2008; 18 1997; 24 2012; 160 2011; 96 2003; 37 2011; 11 2010; 340 2003; 18 2002; 955 2011; 152 2007; 57 2008; 90 2014; 64 2014; 311 2016; 11 2013; 99 2004; 18 2014; 13 2016 2010; 172 2008; 115 2015 2012; 27 2013 2001; 34 1992; 45 2009; 16 Filc D (e_1_2_6_36_1) 2014; 13 Cohen RHR (e_1_2_6_9_1) 2013 IBM Corp (e_1_2_6_21_1) 2013 e_1_2_6_31_1 e_1_2_6_30_1 Israel Central Bureau of Statistics (e_1_2_6_10_1) 2013 Stirbu I (e_1_2_6_37_1) 2011; 11 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_20_1 Schoen C (e_1_2_6_33_1) 2003; 37 e_1_2_6_8_1 Israel Center for Disease Control (e_1_2_6_19_1) 2016 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 Pugsley Z (e_1_2_6_12_1) 2007; 57 e_1_2_6_28_1 e_1_2_6_27_1 02DOECD (e_1_2_6_32_1) 2015 e_1_2_6_26_1 28432722 - BJOG. 2018 Jan;125(1):63 29243360 - BJOG. 2018 Jan;125(1):1 |
| References_xml | – volume: 209 start-page: 3 year: 2016 end-page: 7 article-title: Epidemiology of endometriosis and its comorbidities publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 172 start-page: 237 year: 2010 end-page: 43 article-title: Pelvic endometriosis diagnosed in an entire nation over 20 years publication-title: Am J Epidemiol – volume: 13 start-page: 1 year: 2014 article-title: Is socio‐economic status associated with utilization of health care services in a single‐payer universal health care system? publication-title: International Journal for Equity in Health. – volume: 311 start-page: 2518 year: 2014 end-page: 31 article-title: Decline in estimated glomerular filtration rate and subsequent risk of end‐stage renal disease and mortality publication-title: JAMA – volume: 11 start-page: 1 year: 2011 article-title: Inequalities in utilisation of general practitioner and specialist services in 9 European countries publication-title: BMC Health Serv Res – volume: 152 start-page: 345 year: 2011 end-page: 9 article-title: The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization publication-title: Int J Cardiol – volume: 115 start-page: 1392 year: 2008 end-page: 6 article-title: Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case‐control study–Part 2 publication-title: BJOG: an International Journal of Obstetrics and Gynaecology – year: 2016 – volume: 97 start-page: 202 year: 2010 end-page: 8 article-title: IVF policies with emphasis on Israeli practices publication-title: Health Policy – volume: 18 start-page: 257 year: 2008 end-page: 66 article-title: Cultural and educational disparities in the use of primary and preventive health care services among midlife women in Israel publication-title: Women's Health Issues – volume: 45 start-page: 613 year: 1992 end-page: 619 article-title: Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative databases publication-title: J Clin Epidemiol – volume: 34 start-page: 53 year: 2001 end-page: 69 article-title: Self‐rated health status and health care utilization among immigrant and non‐immigrant Israeli Jewish women publication-title: Women Health – volume: 57 start-page: 470 year: 2007 end-page: 6 article-title: Management of endometriosis in general practice: the pathway to diagnosis publication-title: The British Journal of General practice: The Journal of the Royal College of General Practitioners. – volume: 27 start-page: 3412 year: 2012 end-page: 6 article-title: Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences publication-title: Hum Reprod – volume: 18 start-page: 177 year: 2004 end-page: 200 article-title: Endometriosis: epidemiology and aetiological factors publication-title: Best practice & Research Clinical Obstetrics & Gynaecology. – volume: 99 start-page: 1189 year: 2013 end-page: 96 article-title: In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services publication-title: Fertil Steril – volume: 96 start-page: 366 year: 2011 end-page: 373 article-title: Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries publication-title: Fertil Steril – volume: 340 start-page: c2661 year: 2010 article-title: Endometriosis publication-title: BMJ – start-page: 2014 year: 2013 – volume: 18 start-page: 1143 year: 2003 end-page: 6 article-title: The epidemiology of diabetes in a large Israeli HMO publication-title: Eur J Epidemiol – volume: 17 start-page: 2715 year: 2002 end-page: 24 article-title: High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis publication-title: Hum Reprod – volume: 125 start-page: 959 year: 1987 end-page: 69 article-title: Incidence of pelvic endometriosis in Rochester, Minnesota, 1970‐1979 publication-title: Am J Epidemiol – volume: 160 start-page: 79 year: 2012 end-page: 83 article-title: Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis‐related symptoms: findings from a statutory health insurance‐based cohort in Germany publication-title: Eur J Obstet Gynecol Reprod Biol – volume: 955 start-page: 11 year: 2002 end-page: 22 article-title: The epidemiology of endometriosis publication-title: Ann N Y Acad Sci – volume: 37 start-page: 49 year: 2003 end-page: 70 article-title: Disparities in women's health and health care experiences in the United States and Israel: findings from 1998 National Women's Health Surveys publication-title: Women Health – volume: 24 start-page: 235 year: 1997 end-page: 58 article-title: Epidemiology of endometriosis publication-title: Obstet Gynecol Clin North Am – volume: 82 start-page: 314 year: 2004 end-page: 21 article-title: Incidence and characterization of diagnosed endometriosis in a geographically defined population publication-title: Fertil Steril – volume: 16 start-page: 335 year: 2009 end-page: 46 article-title: Priorities for endometriosis research: recommendations from an international consensus workshop publication-title: Reprod Sci. – volume: 64 start-page: 501 year: 2014 end-page: 7 article-title: Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel publication-title: Hypertension – volume: 115 start-page: 1382 year: 2008 end-page: 91 article-title: Can symptomatology help in the diagnosis of endometriosis? Findings from a national case‐control study–Part 1 publication-title: BJOG: An International Journal of Obstetrics and Gynaecology – volume: 11 start-page: e0154227 year: 2016 article-title: Incidence and estimated prevalence of endometriosis and adenomyosis in Northeast Italy: a data linkage study publication-title: PLoS ONE – year: 2015 – year: 2013 – volume: 90 start-page: 1019 year: 2008 end-page: 25 article-title: Country of birth and hospitalization for pelvic inflammatory disease, ectopic pregnancy, endometriosis, and infertility: a nationwide study of 2 million women in Sweden publication-title: Fertil Steril – ident: e_1_2_6_31_1 doi: 10.1093/oxfordjournals.aje.a114634 – ident: e_1_2_6_25_1 doi: 10.1016/j.fertnstert.2007.07.1345 – ident: e_1_2_6_27_1 doi: 10.1016/j.ejogrb.2016.04.021 – ident: e_1_2_6_16_1 doi: 10.1023/B:EJEP.0000006635.36802.c8 – ident: e_1_2_6_5_1 doi: 10.1016/j.fertnstert.2011.05.090 – volume-title: Health at a Glance: OECD Indicators year: 2015 ident: e_1_2_6_32_1 – volume: 13 start-page: 1 year: 2014 ident: e_1_2_6_36_1 article-title: Is socio‐economic status associated with utilization of health care services in a single‐payer universal health care system? publication-title: International Journal for Equity in Health. doi: 10.1186/s12939-014-0115-1 – volume-title: Israel National Cancer Registry year: 2016 ident: e_1_2_6_19_1 – ident: e_1_2_6_11_1 – ident: e_1_2_6_29_1 doi: 10.1093/humrep/17.10.2715 – ident: e_1_2_6_14_1 doi: 10.1016/j.healthpol.2010.04.004 – ident: e_1_2_6_20_1 doi: 10.1016/0895-4356(92)90133-8 – volume: 37 start-page: 49 year: 2003 ident: e_1_2_6_33_1 article-title: Disparities in women's health and health care experiences in the United States and Israel: findings from 1998 National Women's Health Surveys publication-title: Women Health doi: 10.1300/J013v37n01_04 – volume: 57 start-page: 470 year: 2007 ident: e_1_2_6_12_1 article-title: Management of endometriosis in general practice: the pathway to diagnosis publication-title: The British Journal of General practice: The Journal of the Royal College of General Practitioners. – ident: e_1_2_6_15_1 doi: 10.1016/j.ijcard.2010.08.002 – ident: e_1_2_6_2_1 doi: 10.1016/S0889-8545(05)70302-8 – ident: e_1_2_6_8_1 doi: 10.1177/1933719108330568 – ident: e_1_2_6_26_1 doi: 10.1016/j.bpobgyn.2004.01.007 – ident: e_1_2_6_3_1 doi: 10.1111/j.1749-6632.2002.tb02761.x – start-page: 2014 volume-title: Membership in Sick Funds year: 2013 ident: e_1_2_6_9_1 – ident: e_1_2_6_24_1 doi: 10.1371/journal.pone.0154227 – ident: e_1_2_6_4_1 doi: 10.1136/bmj.c2661 – ident: e_1_2_6_22_1 doi: 10.1111/j.1471-0528.2008.01878.x – ident: e_1_2_6_28_1 doi: 10.1111/j.1471-0528.2008.01879.x – ident: e_1_2_6_6_1 doi: 10.1016/j.ejogrb.2011.09.041 – ident: e_1_2_6_34_1 doi: 10.1300/J013v34n03_04 – ident: e_1_2_6_30_1 doi: 10.1016/j.fertnstert.2004.01.037 – volume: 11 start-page: 1 year: 2011 ident: e_1_2_6_37_1 article-title: Inequalities in utilisation of general practitioner and specialist services in 9 European countries publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-11-288 – ident: e_1_2_6_35_1 doi: 10.1016/j.whi.2007.12.009 – volume-title: Characterization and classification of geographic units by the socio‐economic level of the population 2008 year: 2013 ident: e_1_2_6_10_1 – ident: e_1_2_6_23_1 doi: 10.1093/aje/kwq143 – ident: e_1_2_6_7_1 doi: 10.1093/humrep/des316 – ident: e_1_2_6_17_1 doi: 10.1161/HYPERTENSIONAHA.114.03718 – volume-title: IBM SPSS Statistics for Windows year: 2013 ident: e_1_2_6_21_1 – ident: e_1_2_6_13_1 doi: 10.1016/j.fertnstert.2012.12.029 – ident: e_1_2_6_18_1 doi: 10.1001/jama.2014.6634 – reference: 28432722 - BJOG. 2018 Jan;125(1):63 – reference: 29243360 - BJOG. 2018 Jan;125(1):1 |
| SSID | ssj0016203 |
| Score | 2.6287577 |
| Snippet | Objective
Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is... Endometriosis diagnosed in 1% of women, according to a large population‐based study in a community setting. Endometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is to... ObjectiveEndometriosis constitutes a significant burden on the quality of life of women, their families and healthcare systems. The objective of this study is... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 55 |
| SubjectTerms | Adolescent Adult Age Distribution Chronic illnesses Diagnosis Endometriosis Endometriosis - epidemiology Epidemiology Female Humans Incidence Infertility Infertility, Female - epidemiology Israel - epidemiology Middle Aged Multiple Chronic Conditions - epidemiology Patient Acceptance of Health Care - statistics & numerical data Population studies Population-based studies Prevalence Quality of life Residence Characteristics - statistics & numerical data Retrospective Studies Socioeconomic Factors Young Adult |
| Title | Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1471-0528.14711 https://www.ncbi.nlm.nih.gov/pubmed/28444957 https://www.proquest.com/docview/1977132311 https://www.proquest.com/docview/1892334730 |
| Volume | 125 |
| WOSCitedRecordID | wos000418194800011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1471-0528 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016203 issn: 1470-0328 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8UwEB70KeLFfXluRPDgpdItaerN7SHihii8W0nTFB9oK1YFPfkT_I3-EmfavrohInhLydKQZDLzJZP5ANZ4olFpacfiMg4QoBjHktJ3LVs7aMvR1V-sS7KJ4PhYdrvhae1NSG9hqvgQzYEbSUa5X5OAq7j4IOQObquWzV25QSkEQEMurl7egqHds87FYXOVINySHhkL2RYFj6vj-5A7z5cmPqumb_bmZ_O11D-d8X_o-QSM1cYn26pWyyQMmGwKRo7q6_VpeNp754t9ZHnKTJbk18S5lRe9YpMpdkWO4-ymYf16fX4hPZgw8jSlFCvj1TJ6tYLFLxvvMtZ_8sfo5Je5jOiOsAF2bYiSpJiBi87e-c6-VZMzWNrDTluJEMZTAs1BxDypMX4QuqnEvDCwlaFvLlKRcEQsJlZ2qB2uhBvy1JZxquzEm4VWlmdmHphLfluI_JSjuS9SHfoq9H2diMAzGhFXGzb68xLpOnI5EWhcRX0EQ-MY0YiWKacN602Fmypox89Fl_oTHdXSW0QOGsWI0j3KXm2yUe7oMkVlJr_HMhJNY8_HDbINc9UCaf6FKt9H4Blgx8t18Fsnou2DkzKx8NcKizCKFpyszoSWoHV3e2-WYVg_3PWK2xUYDLpypRaIN_TMBfE |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ZS8QwEA6ior54H-sZwQdfKj3SNPXNa_FYVxAX9q1k0xQXtF22u4I--RP8jf4SZ3p5ISL4lpKjoZ3JzJdM5iNkxw0VGC1lGa7oeABQtGUIwWzDVBb4cnj011EZ2YTXbIp22_94FybPD1FtuKFmZOs1KjhuSH_QcgvWVcN0bbGHJUBAYwyECaR87Pi63mpUZwnczviRoZFpYPa4IsEPxvN8GeKzbfrmcH72XzMDVJ_5j6nPkunC_aQHubzMkREdz5OJy-KAfYE8nbwzxj7SJKI6DpN7ZN1K0m66TyW9w9Bx2qt4v16fX9AShhRjTbFEs4y1FO-tQPPbKr6Mlpf-KO79Upsi4REMQO81kpKki6RVP7k5OjUKegZDOTBpI-RcO5KDQwioJ9Kaeb4dCajzPVNqfHZ5xEMXMIvuSNNXliu57buRKTqRNENniYzGSaxXCLUxcguwn7SUy3ikfCZ9xlTIPUcrwFw1slf-mEAVucuRQuMuKDEMfscAv2hWsmpkt-rQy9N2_Nx0vfzTQaG_aWCBWww43cHq7aoaNA-PU2SskyG0EeAcOwyWyBpZziWkehcYfQbQ04OJZ4Lw2ySCw_OrrLD61w5bZPL05rIRNM6aF2tkCvw5ke8QrZPRQX-oN8i4ehh00_5moRdvh9II-Q |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8UwEB7kKeLFfXmuETx4qXRJ09Sb28P1KaLgreSlKQraPqwKevIn-Bv9Jc60fXVDRPCWkqUhyWTmSybzAaz4sUalpR3Ll50AAYpxLCm5a9naQVuOrv46uiCbCNpteXERfnwLU8aHqA_cSDKK_ZoE3HTj5IOUO7ivWrbvyjVKIQLq50Ql04D-7dPW-WF9lyDcgh8ZC9kWRY-rAvyQP8-XJj7rpm8G52f7tVBArZH_6PooDFfmJ9so18sY9Jl0HAaPqgv2CXjaeWeMfWRZwkwaZzfEupXlV_k6U-yaXMdZt-b9en1-IU0YM_I1pRQrItYyereCxS9r_zLWe_TH6OyXuYwIj7ABdmOIlCSfhPPWztnWrlXRM1jaw05bsRDGUwINQkQ9iTE8CN1EYl4Y2MrQty8SEfuIWUxH2aF2fCXc0E9s2UmUHXtT0Eiz1MwAc8lzC7GfcrTPRaJDrkLOdSwCz2jEXE1Y601MpKvY5UShcR31MAyNY0QjWqScJqzWFbpl2I6fi873Zjqq5DePHDSLEad7lL1cZ6Pk0XWKSk12j2UkGscexy2yCdPlCqn_hUqfI_QMsOPFQvitE9Hm_nGRmP1rhSUYPNluRYd77YM5GEJzTpYHRPPQuLu9NwswoB_urvLbxUos3gACjgh0 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+endometriosis%3A+a+large+population-based+database+study+from+a+healthcare+provider+with+2+million+members&rft.jtitle=BJOG+%3A+an+international+journal+of+obstetrics+and+gynaecology&rft.au=Eisenberg%2C+V+H&rft.au=Weil%2C+C&rft.au=Chodick%2C+G&rft.au=Shalev%2C+V&rft.date=2018-01-01&rft.eissn=1471-0528&rft.volume=125&rft.issue=1&rft.spage=55&rft_id=info:doi/10.1111%2F1471-0528.14711&rft_id=info%3Apmid%2F28444957&rft.externalDocID=28444957 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1470-0328&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1470-0328&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1470-0328&client=summon |